1
|
de Oliveira Della Senta D, Cardoso G, Neis A, de Sousa GF, do Amaral DS, de Farias CJ, da Silva Pinto L. Antifungal Effect of Bauhinia variegata Lectin (BvL) on Bipolaris oryzae. Curr Microbiol 2024; 81:329. [PMID: 39190055 DOI: 10.1007/s00284-024-03848-w] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/08/2024] [Accepted: 08/15/2024] [Indexed: 08/28/2024]
Abstract
The search for less harmful, ecologically efficient, more specific, and natural alternatives for the control of pathogens is essential. Bauhinia variegata lectin (BvL) is a protein that has numerous biological activities, including antifungal. The present study examines the potential in vitro of B. variegata lectin against the fungus Bipolaris oryzae, responsible for agricultural losses in southern Brazil, due to damage to rice fields during seed germination. Bioassays to assess the inhibition potential of BvL were performed, including fungal growth, spore formation, and germination, in concentrations of 0, 25, 50, and 100 µg mL-1. Only the concentration of 100 µg mL-1 successfully inhibited mycelial growth and spore germination, while in spore formation, all treatments inhibited sporulation. In addition, fluorescence microscopy analysis demonstrated the ability of lectin to bind to the fungus and the lack of detection in the presence of lactose, suggesting its interaction with the fungal cell wall structures. This study highlights the potential of B. variegata seed lectin to control mycelial growth, sporulation, and germination of the phytopathogenic fungus B. oryzae, posing as a new biotechnological possibility for biological control.
Collapse
Affiliation(s)
- Danillo de Oliveira Della Senta
- Programa de Pós-Graduação em Biotecnologia, Laboratório Bioinformática e Proteômica (BioPro Lab), Centro de Desenvolvimento Tecnológico, Universidade Federal de Pelotas, Campus Universitário, s/n - Prédio 19, Pelotas, RS, 96010-900, Brazil
| | - Guilherme Cardoso
- Programa de Pós-Graduação em Biotecnologia, Laboratório Bioinformática e Proteômica (BioPro Lab), Centro de Desenvolvimento Tecnológico, Universidade Federal de Pelotas, Campus Universitário, s/n - Prédio 19, Pelotas, RS, 96010-900, Brazil
| | - Alessandra Neis
- Programa de Pós-Graduação em Biotecnologia, Laboratório Bioinformática e Proteômica (BioPro Lab), Centro de Desenvolvimento Tecnológico, Universidade Federal de Pelotas, Campus Universitário, s/n - Prédio 19, Pelotas, RS, 96010-900, Brazil
| | - Guilherme Feijó de Sousa
- Programa de Pós-Graduação em Biotecnologia, Laboratório Bioinformática e Proteômica (BioPro Lab), Centro de Desenvolvimento Tecnológico, Universidade Federal de Pelotas, Campus Universitário, s/n - Prédio 19, Pelotas, RS, 96010-900, Brazil
| | - Diego Serrasol do Amaral
- Programa de Pós-Graduação em Biotecnologia, Laboratório Bioinformática e Proteômica (BioPro Lab), Centro de Desenvolvimento Tecnológico, Universidade Federal de Pelotas, Campus Universitário, s/n - Prédio 19, Pelotas, RS, 96010-900, Brazil
| | | | - Luciano da Silva Pinto
- Programa de Pós-Graduação em Biotecnologia, Laboratório Bioinformática e Proteômica (BioPro Lab), Centro de Desenvolvimento Tecnológico, Universidade Federal de Pelotas, Campus Universitário, s/n - Prédio 19, Pelotas, RS, 96010-900, Brazil.
| |
Collapse
|
2
|
The Updated Review on Plant Peptides and Their Applications in Human Health. Int J Pept Res Ther 2022; 28:135. [PMID: 35911180 PMCID: PMC9326430 DOI: 10.1007/s10989-022-10437-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 06/20/2022] [Indexed: 11/30/2022]
Abstract
Biologically active plant peptides, consisting of secondary metabolites, are compounds (amino acids) utilized by plants in their defense arsenal. Enzymatic processes and metabolic pathways secrete these plant peptides. They are also known for their medicinal value and have been incorporated in therapeutics of major human diseases. Nevertheless, its limitations (low bioavailability, high cytotoxicity, poor absorption, low abundance, improper metabolism, etc.) have demanded a need to explore further and discover other new plant compounds that overcome these limitations. Keeping this in mind, therapeutic plant proteins can be excellent remedial substitutes for bodily affliction. A multitude of these peptides demonstrates anti-carcinogenic, anti-microbial, anti-HIV, and neuro-regulating properties. This article's main aim is to list out and report the status of various therapeutic plant peptides and their prospective status as peptide-based drugs for multiple diseases (infectious and non-infectious). The feasibility of these compounds in the imminent future has also been discussed.
Collapse
|
3
|
Ahmed MN, Jahan R, Nissapatorn V, Wilairatana P, Rahmatullah M. Plant lectins as prospective antiviral biomolecules in the search for COVID-19 eradication strategies. Biomed Pharmacother 2022; 146:112507. [PMID: 34891122 PMCID: PMC8648558 DOI: 10.1016/j.biopha.2021.112507] [Citation(s) in RCA: 14] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/20/2021] [Revised: 12/02/2021] [Accepted: 12/03/2021] [Indexed: 12/12/2022] Open
Abstract
Lectins or clusters of carbohydrate-binding proteins of non-immune origin are distributed chiefly in the Plantae. Lectins have potent anti-infectivity properties for several RNA viruses including SARS-CoV-2. The primary purpose of this review is to review the ability of lectins mediated potential biotherapeutic and bioprophylactic strategy against coronavirus causing COVID-19. Lectins have binding affinity to the glycans of SARS-COV-2 Spike glycoprotein that has N-glycosylation sites. Apart from this, the complement lectin pathway is a "first line host defense" against the viral infection that is activated by mannose-binding lectins. Mannose-binding lectins deficiency in serum influences innate immunity of the host and facilitates infectious diseases including COVID-19. Our accumulated evidence obtained from scientific databases particularly PubMed and Google Scholar databases indicate that mannose-specific/mannose-binding lectins (MBL) have potent efficacies like anti-infectivity, complement cascade induction, immunoadjuvants, DC-SIGN antagonists, or glycomimetic approach, which can prove useful in the strategy of COVID-19 combat along with the glycobiological aspects of SARS-CoV-2 infections and antiviral immunity. For example, plant-derived mannose-specific lectins BanLac, FRIL, Lentil, and GRFT from red algae can inhibit and neutralize SARS-CoV-2 infectivity, as confirmed with in-vitro, in-vivo, and in-silico assessments. Furthermore, Bangladesh has a noteworthy resource of antiviral medicinal plants as well as plant lectins. Intensifying research on the antiviral plant lectins, adopting a glyco-biotechnological approach, and with deeper insights into the "glycovirological" aspects may result in the designing of alternative and potent blueprints against the 21st century's biological pandemic of SARS-CoV-2 causing COVID-19.
Collapse
Affiliation(s)
- Md Nasir Ahmed
- Department of Biotechnology & Genetic Engineering, University of Development Alternative, Dhaka, Bangladesh; Biotechnology & Natural Medicine Division, TechB Nutrigenomics, Dhaka, Bangladesh.
| | - Rownak Jahan
- Department of Biotechnology & Genetic Engineering, University of Development Alternative, Dhaka, Bangladesh.
| | - Veeranoot Nissapatorn
- School of Allied Health Sciences and World Union for Herbal Drug Discovery (WUHeDD), Walailak University, Nakhon Si Thammarat, Thailand
| | - Polrat Wilairatana
- Department of Clinical Tropical Medicine, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.
| | - Mohammed Rahmatullah
- Department of Biotechnology & Genetic Engineering, University of Development Alternative, Dhaka, Bangladesh.
| |
Collapse
|
4
|
Wani SS, Dar PA, Zargar SM, Dar TA. Therapeutic Potential of Medicinal Plant Proteins: Present Status and Future Perspectives. Curr Protein Pept Sci 2021; 21:443-487. [PMID: 31746291 DOI: 10.2174/1389203720666191119095624] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/22/2019] [Revised: 10/10/2019] [Accepted: 10/27/2019] [Indexed: 02/07/2023]
Abstract
Biologically active molecules obtained from plant sources, mostly including secondary metabolites, have been considered to be of immense value with respect to the treatment of various human diseases. However, some inevitable limitations associated with these secondary metabolites like high cytotoxicity, low bioavailability, poor absorption, low abundance, improper metabolism, etc., have forced the scientific community to explore medicinal plants for alternate biologically active molecules. In this context, therapeutically active proteins/peptides from medicinal plants have been promoted as a promising therapeutic intervention for various human diseases. A large number of proteins isolated from the medicinal plants have been shown to exhibit anti-microbial, anti-oxidant, anti-HIV, anticancerous, ribosome-inactivating and neuro-modulatory activities. Moreover, with advanced technological developments in the medicinal plant research, medicinal plant proteins such as Bowman-Birk protease inhibitor and Mistletoe Lectin-I are presently under clinical trials against prostate cancer, oral carcinomas and malignant melanoma. Despite these developments and proteins being potential drug candidates, to date, not a single systematic review article has documented the therapeutical potential of the available biologically active medicinal plant proteome. The present article was therefore designed to describe the current status of the therapeutically active medicinal plant proteins/peptides vis-à-vis their potential as future protein-based drugs for various human diseases. Future insights in this direction have also been highlighted.
Collapse
Affiliation(s)
- Snober Shabeer Wani
- Department of Clinical Biochemistry, University of Kashmir, Srinagar-190006, Jammu and Kashmir, India
| | - Parvaiz A Dar
- Department of Clinical Biochemistry, University of Kashmir, Srinagar-190006, Jammu and Kashmir, India
| | - Sajad M Zargar
- Division of Plant Biotechnology, S. K. University of Agricultural Sciences and Technology of Srinagar, Shalimar-190025, Srinagar, Jammu and Kashmir, India
| | - Tanveer A Dar
- Department of Clinical Biochemistry, University of Kashmir, Srinagar-190006, Jammu and Kashmir, India
| |
Collapse
|
5
|
Cavada BS, Pinto-Junior VR, Osterne VJS, Oliveira MV, Lossio CF, Silva MTL, Bari AU, Lima LD, Souza-Filho CHD, Nascimento KS. Comprehensive review on Caelsalpinioideae lectins: From purification to biological activities. Int J Biol Macromol 2020; 162:333-348. [DOI: 10.1016/j.ijbiomac.2020.06.161] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/20/2020] [Revised: 06/15/2020] [Accepted: 06/17/2020] [Indexed: 12/13/2022]
|